Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892969 · ClinicalTrials.gov registry record
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 304
- Enrollment target
NCT01892969: Completed study, sponsored by University of California, San Francisco.
NCT01892969 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 304 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01892969 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
Study Summary
Project Summary We propose an ancillary study to The Heart and Lung Failure Pediatric Insulin Titration trial (HALF PINT), which is investigating the impact of normalizing blood glucose using insulin infusions on clinical outcomes among children with hyperglycemia and heart and lung failure. In this ancillary study, we will measure plasma levels of inflammatory, coagulation, and fibrinolysis proteins and genotype DNA for polymorphisms among patients enrolled in the HALF PINT trial. The results from this ancillary study will help us to understand potential mechanisms through which normalizing blood glucose provides benefit, which may lead to development of new therapeutic strategies in critically ill children
Primary Outcome
The researchers will measure IL-6, IL-8 and PAI-1 on patient plasma using a Luminex based multiplex array. All measurements are in pg/mL. The Slope of change in biomarkers from the time of start of insulin infusion to 2 and 4 days after start of insulin infusion will be used as the outcome measure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-09 |
What the finished NCT01892969 record still lists
NCT01892969 is an observational study that tracks outcomes without assigning an intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01892969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01892969 about?
NCT01892969 is a clinical study titled "Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)". Project Summary We propose an ancillary study to The Heart and Lung Failure Pediatric Insulin Titration trial (HALF PINT), which is investigating the impact of normalizing blood glucose using insulin infusions on clinical outcomes among children with hyperglycemia and heart and lung failure. In this...
What is the current status of trial NCT01892969?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2012-10. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01892969?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia